In addition to its role in breast cancer, ZMYND8 is upregulated and promotes tumor growth in multiple cancer models, including acute myeloid leukemia, bladder cancer, clear cell renal cell carcinoma, colorectal cancer, glioblastoma, and liver cancer (13, 15–17, 19–23). This evidence concerns the gene ZMYND8 and breast carcinoma.